Table of Contents
The drug development pipeline outlines the steps required to move potential treatments for myotonic dystrophy from early discovery through clinical trials and toward regulatory approval. Understanding this process helps individuals and families better follow research progress, clinical trial opportunities, and the path toward safe and effective therapies.
